Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk

By  

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2432-2438

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of glycine on the cyclooxygenase pathway of the kidney arachidonic acid metabolism in a rat model of metabolic syndrome

By Pérez-Torres Israel   Ibarra Blanca   Soria-Castro Elizabeth   Torrico-Lavayen Rocío   Pavón Natalia   Diaz-Diaz Eulises   Flores Pedro L.   Infante Oscar   Baños Guadalupe  

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 12, 2011-12 ,pp. : 899-910

NRC Research Press

Access to resources Recommend Favorite

Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 3, 2018-04 ,pp. : 251-259

Bentham Science Publishers

Access to resources Recommend Favorite

NAD Metabolism and Functions: A Common Therapeutic Target for Neoplastic, Metabolic and Neurodegenerative Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 23, 2013-12 ,pp. : 2918-2929

Bentham Science Publishers

Access to resources Recommend Favorite

Ghrelin Receptor Signaling: A Promising Therapeutic Target for Metabolic Syndrome and Cognitive Dysfunction

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 557-563

Bentham Science Publishers

Access to resources Recommend Favorite